Search for dissertations about: "Onkologi"
Showing result 1 - 5 of 1101 swedish dissertations containing the word Onkologi.
-
1. Clinical application of intensity and energy modulated radiotherapy with photon and electron beams
University dissertation from Umeå : StrålningsvetenskaperAbstract : In modern, advanced radiotherapy (e.g. intensity modulated photon radiotherapy, IMXT) the delivery time for each fraction becomes prolonged to 10-20 minutes compared with the conventional, commonly 2-5 minutes. The biological effect of this prolongation is not fully known. READ MORE
-
2. ARCON in experimental and clinical radiotherapy
University dissertation from Umeå : StrålningsvetenskaperAbstract : xHypoxia and repopulation of tumour clonogens are two important determinants of treatment outcome in radiotherapy. In general clinical evidence indicates that loco-regional control may be reduced with long overall treatment times and for tumours with low pre-treatment levels of oxygen. READ MORE
-
3. Human secretoglobins in normal and neoplastic cells and tissues
University dissertation from Umeå : Umeå universitetAbstract : Secretoglobins is a newly described polypeptide family that has gained a lot of interest in human cancer and inflammation research. Although the first secretoglobin polypeptide was discovered more than 30 years ago, their physiological function is still not known. READ MORE
-
4. Radiosensitivity in lung cancer with focus on p53
University dissertation from Uppsala : Acta Universitatis UpsaliensisAbstract : In Sweden approximately 2800 new lung cancer patients are diagnosed every year. Radiotherapy is used with curative intention in certain groups of patients. The aim of this thesis is to study the basis of differences in radioresistance and the possibility to predict response to radiotherapy. READ MORE
-
5. Vaccine Therapy of Colorectal Cancer Patients with Tumor Associated Antigens
University dissertation from Uppsala : Acta Universitatis UpsaliensisAbstract : In this thesis, two different vaccines were evaluated as adjuvant therapy for patients with colorectal cancer. The ability of the two candidate vaccines to generate antigen-specific cellular and humoral responses, respectively, was studied. READ MORE
